Fredén F, Wei S Z, Berglund J E, Frostell C, Hedenstierna G
Department of Clinical Physiology, Uppsala University Hospital, Sweden.
Anesthesiology. 1995 May;82(5):1216-25. doi: 10.1097/00000542-199505000-00017.
Nitric oxide, endogenously produced or inhaled, has been shown to play an important role in the regulation of pulmonary blood flow. The inhalation of nitric oxide reduces pulmonary arterial pressure in humans, and the blockade of endogenous nitric oxide production increases the pulmonary vascular response to hypoxia. This study was performed to investigate the hypothesis that intravenous administration of an nitric oxide synthase inhibitor and regional inhalation of nitric oxide can markedly alter the distribution of pulmonary blood flow during regional hypoxia.
Hypoxia (5% O2) was induced in the left lower lobe of the pig, and the blood flow to this lobe was measured with transit-time ultrasound. Nitric oxide was administered in the gas ventilating the hypoxic lobe and the hyperoxic lung regions with and without blockade of endogenous nitric oxide production by means of N omega-nitro-L-arginine methyl ester (L-NAME).
Hypoxia in the left lower lobe reduced blood flow to that lobe to 27 +/- 3.9% (mean +/- SEM) of baseline values (P < 0.01). L-NAME caused a further reduction in lobar blood flow in all six animals to 12 +/- 3.5% and increased arterial oxygen tension (PaO2) (P < 0.01). Without L-NAME, the inhalation of nitric oxide (40 ppm) to the hypoxic lobe increased lobar blood flow to 66 +/- 5.6% of baseline (P < 0.01) and, with L-NAME, nitric oxide delivered to the hypoxic lobe resulted in a lobar blood flow that was 88 +/- 9.3% of baseline (difference not significant). When nitric oxide was administered to the hyperoxic lung regions, after L-NAME infusion, the blood flow to the hypoxic lobe decreased to 2.5 +/- 1.6% of baseline and PaO2 was further increased (P < 0.01).
By various combinations of nitric oxide inhalation and intravenous administration of an nitric oxide synthase inhibitor, lobar blood flow and arterial oxygenation could be markedly altered during lobar hypoxia. In particular, the combination of intravenous L-NAME and nitric oxide inhalation to the hyperoxic regions almost abolished perfusion of the hypoxic lobe and resulted in a PaO2 that equalled the prehypoxic values. This possibility of adjusting regional blood flow and thereby of improving PaO2 may be of value in the treatment of patients undergoing one-lung ventilation and of patients with acute respiratory failure.
内源性产生或吸入的一氧化氮已被证明在肺血流调节中起重要作用。吸入一氧化氮可降低人体肺动脉压,而阻断内源性一氧化氮的产生会增加肺血管对缺氧的反应。本研究旨在探讨静脉注射一氧化氮合酶抑制剂并局部吸入一氧化氮能否在局部缺氧期间显著改变肺血流分布这一假说。
在猪的左下叶诱导缺氧(5%氧气),并用渡越时间超声测量该叶的血流。在有或没有通过Nω-硝基-L-精氨酸甲酯(L-NAME)阻断内源性一氧化氮产生的情况下,将一氧化氮给予通气于缺氧叶和高氧肺区域的气体中。
左下叶缺氧使该叶血流降至基线值的27±3.9%(平均值±标准误)(P<0.01)。L-NAME使所有6只动物的叶血流进一步降至12±3.5%,并增加了动脉血氧张力(PaO2)(P<0.01)。在没有L-NAME的情况下,向缺氧叶吸入一氧化氮(40 ppm)使叶血流增加至基线的66±5.6%(P<0.01),而在使用L-NAME时,给予缺氧叶的一氧化氮使叶血流达到基线的88±9.3%(差异不显著)。在L-NAME输注后,当向高氧肺区域给予一氧化氮时,缺氧叶的血流降至基线的2.5±1.6%,且PaO2进一步升高(P<0.01)。
通过一氧化氮吸入和静脉注射一氧化氮合酶抑制剂的各种组合,在叶性缺氧期间叶血流和动脉氧合可被显著改变。特别是,静脉注射L-NAME并向高氧区域吸入一氧化氮的组合几乎消除了缺氧叶的灌注,并使PaO2等于缺氧前的值。这种调节局部血流从而改善PaO2的可能性可能对接受单肺通气的患者和急性呼吸衰竭患者的治疗有价值。